IR@PKUHSC  > 北京大学深圳医院  > 泌尿外科
学科主题临床医学
Overactive bladder symptom score to evaluate efficacy of solifenacin for the treatment of overactive bladder symptoms
Liu Ming1; Wang Jianye1; Yang Yong2; An Ruihua3; Wen Jianguo4; Guan Zhichen5; Zheng Shaobin6; Wang Dongwen7; Song Bo8; Liao Limin9; Guo Hongqian10; Xiao Jiaquan11; Sun Yinghao12; Shen Zhoujun13; Kong Chuize14; He Dalin15; Huang Yiran16; Wang Xiaofeng17; Zhang Xu18; Li Hanzhong19; Huang Jian20; Zhao Xiaokun21; Zeng Puqing22; Song Xishuang23; Ye Zhangqun24
关键词Overactive Bladder Muscarinic Antagonists Symptom Score
刊名CHINESE MEDICAL JOURNAL
2014-01-20
DOI10.3760/cma.j.issn.0366-6999.20131349
127期:2页:261-265
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]PLACEBO-CONTROLLED TRIAL ; URINARY-TRACT SYMPTOMS ; DOUBLE-BLIND ; TOLTERODINE ; URGENCY ; INCONTINENCE ; TOLERABILITY ; SUCCINATE ; SEVERITY ; IMPROVES
英文摘要

Background Overactive bladder (OAB) is a series of symptoms with high prevalence in elderly people. This study was conducted using the overactive bladder symptom score (OABSS) to evaluate the efficacy of solifenacin succinate for the treatment of OAB.

Methods This was a prospective, multicenter, single-arm, 12-week study that enrolled 241 OAB patients. The patients received 5-10 mg/day solifenacin. Changes in OABSS, symptoms from voiding diary, perception of bladder condition (PPBC) score, international prostate symptom score (IPSS) and quality of life (QOL) were evaluated at weeks 0, 4, and 12. The relationship between OABSS and PPBC score or parameters of voiding diary was also evaluated.

Results At baseline, the mean OABSS for all patients was 9.41 +/- 2.40, and was reduced significantly at week 12 (-3.76 points; 61.21%, P <0.0001). The OABSS subscore, PPBC score, IPSS, and QOL were also significantly reduced during the study (P <0.0001). The overall incidence of adverse events was 19.91% (44 cases). The gastrointestinal system was the most commonly affected (11.31%). Around 5.88% of the cases had adverse events related to the genitourinary system. There was a strong correlation between OABSS and urinary symptoms that was recorded in the 3-day voiding dairy.

Conclusions We showed that solifenacin was clinically effective for relieving OAB symptoms, considering the balance between efficacy, patients′ well-being, and tolerability. OABSS integrates four OAB symptoms into a single score and can be a useful tool for research and clinical practice.

语种英语
WOS记录号WOS:000330606900010
资助机构Astellas Pharma China, Ltd.
引用统计
被引频次:2[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/53176
专题北京大学深圳医院_泌尿外科
作者单位1.Beijing Hosp, Dept Urol, Beijing 100730, Peoples R China
2.Beijing Chao Yang Hosp, Dept Urol, Beijing 100730, Peoples R China
3.Harbin Med Univ, Clin Coll 1, Dept Urol, Harbin 150001, Heilongjiang, Peoples R China
4.Zhengzhou Univ, Affiliated Hosp 1, Dept Urol, Zhengzhou 450003, Henan, Peoples R China
5.Peking Univ, Shenzhen Hosp, Dept Urol, Shenzhen 518036, Guangdong, Peoples R China
6.Nan Fang Hosp, Dept Urol, Guangzhou 440100, Guandong, Peoples R China
7.Shanxi Med Univ, Clin Coll 1, Dept Urol, Taiyuan 030012, Shanxi, Peoples R China
8.China Rehabil Ctr, Dept Urol, Beijing 100068, Peoples R China
9.Changhai Hosp Shanghai, Dept Urol, Shanghai 200433, Peoples R China
10.Southwest Hosp, Dept Urol, Chongqing 400038, Peoples R China
11.Nanjing Univ, Sch Med, Affiliated Hosp, Dept Urol,Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China
12.Zhejiang Prov Peoples Hosp, Dept Urol, Hangzhou 310014, Zhejiang, Peoples R China
13.Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Urol, Shanghai 200025, Peoples R China
14.China Med Univ, Hosp 1, Dept Urol, Shenyang 110001, Liaoning, Peoples R China
15.Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Urol, Xian 710061, Shaanxi, Peoples R China
16.Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, Shanghai 200127, Peoples R China
17.Peking Univ, Peoples Hosp, Dept Urol, Beijing 100044, Peoples R China
18.Gen Hosp Peoples Liberat Army, Dept Urol, Beijing 100039, Peoples R China
19.Beijing Union Med Coll Hosp, Dept Urol, Beijing 100005, Peoples R China
20.Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510120, Guangdong, Peoples R China
21.Cent S Univ, Xiangya Hosp 2, Dept Urol, Changsha 410011, Hunan, Peoples R China
22.Wuhan Union Hosp, Dept Urol, Wuhan 430022, Hubei, Peoples R China
23.Dalian Med Univ, Dept Urol, Affiliated Hosp 1, Dalian 116600, Liaoning, Peoples R China
24.Huazhong Univ Sci, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430030, Hubei, Peoples R China
推荐引用方式
GB/T 7714
Liu Ming,Wang Jianye,Yang Yong,et al. Overactive bladder symptom score to evaluate efficacy of solifenacin for the treatment of overactive bladder symptoms[J]. CHINESE MEDICAL JOURNAL,2014,127(2):261-265.
APA Liu Ming.,Wang Jianye.,Yang Yong.,An Ruihua.,Wen Jianguo.,...&Ye Zhangqun.(2014).Overactive bladder symptom score to evaluate efficacy of solifenacin for the treatment of overactive bladder symptoms.CHINESE MEDICAL JOURNAL,127(2),261-265.
MLA Liu Ming,et al."Overactive bladder symptom score to evaluate efficacy of solifenacin for the treatment of overactive bladder symptoms".CHINESE MEDICAL JOURNAL 127.2(2014):261-265.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Liu Ming]的文章
[Wang Jianye]的文章
[Yang Yong]的文章
百度学术
百度学术中相似的文章
[Liu Ming]的文章
[Wang Jianye]的文章
[Yang Yong]的文章
必应学术
必应学术中相似的文章
[Liu Ming]的文章
[Wang Jianye]的文章
[Yang Yong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。